版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
腎內(nèi)科uti的課件資料第1頁/共48頁Generalremarks
Inthischapter,UTIresultingfrombacterialinvasionisdiscussed.Anatomically.
Itisdividedintouppertracturinaryinfection(pyelonephritis)andlowertracturinaryinfection(cystitis)incidence:UTIisacommondisease(2%inpopulation),particularlyinfemaleadults(10%).第2頁/共48頁第3頁/共48頁Etiologyandpathogenesis
Pathogen:
gram-negativebacteria(Specificallycoliformbacteria,proteusbacteria)Pyocyanicinfectionisfrequentlyseeninpatientswithinstrumentation.Proteusbacteriaisoftenseeninpatientswithcalculus.第4頁/共48頁BacterialvirulencefactorsAhighdegreeofbacterialadherence,whichismediatedbythebacterialfimbriae.Somebacteriacanproducehemolysinwhichcanresistthebody’sdefensesystem.Drugresistancestrains第5頁/共48頁第6頁/共48頁HostdefensemechanismsEfficientemptyingofthebladderwithvoiding.Aprotectiveglycosaminoglycanlayer.ThehighosmolalityandextremesofpH.IgG,IgAandorganicacidsecretedbyurinarytractmucosa.第7頁/共48頁HostsusceptibilityfactorsurinarytractObstructionsuchascalculus,vesicoureteralrefluxorintrarenalreflux.
(thepresenceofUTIwithstructurallyorfunctionallyabnormalurinarytractiscalledcomplicatedUTI)ThedeformityofurinarysystemInstrumentationoftheurinarytractHostdefensesystemgetweak,forinstance,diabetesmellitusPregnancy,genderneurogenic
bladderGenetic
factor第8頁/共48頁InfectionrouteTheascendingroute:periurethraltissues→urethra→bladder→ureter→renalpelvis→renalmedullaThehematogenousrouteLymphogenousspreadDirectextensionfromotherorgansmayoccur第9頁/共48頁第10頁/共48頁第11頁/共48頁ClinicalmanifestationcystitisIrritativevoidingsymptomsfrequency,urgency,dysuria(burningordiscomfortonurination),suprapubicdiscomfortUrinalysispyuria,bacteriuria,hematuriaBloodtest:generallynormal
第12頁/共48頁Acutepyelonephritis
Irritativevoidingsymptoms,flankpain.Systemictoxicityfever,shakingchills,nausea,vomitingSigntendernessofureterspotonpalpation,exquisitetendernessonpercussionofthecostovertebralangle.LaboratoryfindingsBloodtest:leukocytosisandaleftshit.Urinalysis:pyuria,bacteriuria,hematuria.Bloodculture:maybepositive.第13頁/共48頁
Asymptomaticbacteriuria
nosymptomispresent,yetbacteriuriaexists.第14頁/共48頁Laboratoryfindings
Urinalysisafindingof≥5WBC/Hpor≥8000WBC/ml↓UTIwhitecellcasts→pyelonephritis.hematuria,proteinuria第15頁/共48頁LaboratoryfindingsDetectionofbacteriuriaCollectionofurinesample:Theurineiscollectedinmidstreambeforedrugisusedoratleast7daysafterdrugadministration.Avoidingcontamination,beingsenttothelaboratorywithin1h.第16頁/共48頁
UrinecultureCFUs≥105/ml→significantbacteriuria.CFUsbetween104~105/ml→suspectedUTI→reexaminationCFUs<104/ml→maybecontamination
(Qualitative
urineculture:iftheurineforcultureisfromcystpuncture,thenwhenpositive,itindicateatrueUTI)第17頁/共48頁第18頁/共48頁
Urinesmearexaminedbymicroscopy
when≥1bacteriuria/oil-immersedHP
Chemicaltestforbacteriuria
Nitratereductiontest
thetestisdependentonthebacterialreductionofnitrateintheurinetonitrite.itiseffectiveinidentifyinginfectionduetogram-negativebacteria.第19頁/共48頁Imaging
IndicationAllmalepatientsFemalepatientrecurrentUTIcomplicatedUTIdisappointingresponsetoantimicrobialtherapy4.everinfectedduringpregnancy第20頁/共48頁ImagingstudiesincludeUltrasonographyIntravenouspyelogram(IVP)Computedtomography
Notice
IVPshouldnotbedoneintheacutephaseofUTI.第21頁/共48頁DiagnosisOFUTIsignificantbacteriuriaApositiveresultofurinecultureinwhichurinespecimenisfromcystpuncture.Quantitativeurineculture:apatientbeingsymptomatic,CFUs≥105/mlforonce.apatientbeingasymptomatic,CFUs≥105/mlfortwice(itshouldbethesamespecies)
第22頁/共48頁DiagnosisOFUTIwhenafemalepatientwithirritativevoidingsymptomandCFUs≥102/ml,UTIshouldbeconsideredandtreatmentforUTIshouldbegiven.
第23頁/共48頁Infection-localizingdiagnosisurinecultureafterbladderwashouttheassayforantibody-coatedbacteria(ACB)urinaryconcentratingability,urineβ2-MG,urinewhitecellcast.第24頁/共48頁
bilateralureteralcatheterrization.
itistooinvasiveforgeneraluse.clinicalpractice1.acutepyelonephritisfever(T>38℃),shakingchills,backpain,WBC↑tendernessonpercussionofthecostovertebralangle2.3daysofantibioticstreatment,ifbeingcured→cystitis,ifnot→pyelonephritis.第25頁/共48頁Chronicpyelonephritis:
thecorticalscarringacorrespondingcalicealdeformitytubuledamageandinterstitial
inflammationandscarring
第26頁/共48頁Differentialdiagnosis
1.renaltuberculosis
aprominentirritativevoidingsymptomnullitytocommonantibioticsmycobacteriuminurinePPD(+)stricture,cavities,calcificationinIVP第27頁/共48頁第28頁/共48頁第29頁/共48頁第30頁/共48頁第31頁/共48頁2.urethralsyndrome:
exhibitirritativevoidingsymptomnosignificantbacteriuriaInfectiveurethralsyndrome:
causedbyotherpathogenssuchasvirus,mycoplasms,chlamydia.Urinalysisshowpyuria.
Non-Infectiveurethralsyndrome:noWBCisseenwithurinalysis.Probablyitisbecauseofpsychologicalproblems.第32頁/共48頁treatmentAntibiotics
G—Bacillus(sulfonamide,quinolones,β-lactamdrugsemisytheticpenicillins,cephalosporins)Afterthedrugsensitivitytestforoffendingorganismsisavailable,thenantibioticsaregivenaccordingtothetest.
第33頁/共48頁Acutecystitis:singledosetherapyanda3-daycourseoftherapy
↓followeduptoseewhethertheinfectioniscontrolledornotitshouldnotbeusedinpatientswithpregnancy,complicatedinfection,suspectedpyelonephritisormalepatients第34頁/共48頁
Acutepyelonephritis
intensiveantimicrobialtherapyshouldbeadministrated.antibioticsfor14daysorally.noeffectwithin72h→adjustthetreatment.
Moderateacutepyelonephritis:intravenoustherapyofantibiotics↓defervescesfor72horalagentatleast14days
第35頁/共48頁
Acutepyelonephritis
Severeacutepyelonephritis:
acombinationofantibioticsaregivenintravenously,oftenanaminoglycosidecombinedwithaβ-lactamdrugorcephalosporins.第36頁/共48頁
TherapyforrecurrentUTI:Relapsinginfection:
infectionoccurwithin6wofthecessationofantimicrobialtherapyandiscausedbythesameorganism.Reinfection:
causedbyanorganismwhichisdifferentfromtheoriginalone.第37頁/共48頁
TherapyforrecurrentUTI:
receiveshortcoursetherapyof7days→followedup7daysaftercessationoftherapy.Ifnosymptom,bacteriuriaandpyuria→curereinfection;Stillwithsymptoms,bacteriuriaandpyuria→treataccordingtodrugsensitivitytest.IfsucceededReinfection,iffailed→abigdoseantimicrobialsfor6weeks.patientswithmorethan3UTIs/years→longtermprophylaxistherapy.第38頁/共48頁treatmenturinarytractinfectioninpregnancychoosedrugsthataresafetofetus(ampicillincephalexin)asymptomaticbacteriuriaWomeninpregnancy,childrenbeforeschool-age,previoussymptomaticUTI,withcomplicatedfactors---shouldreceivetreatment.第39頁/共48頁Complication
Acuterenalpapillarynecrosis:accompaniedbydiabetesorurinarytractobstruction.leadtosepsisorARF.presentwithhighfever,severebackpain,hematuria,andureterobstructiontreatment:strengthenantimicrobialtherapy,andobstr
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度年度知名教育機構(gòu)兼職教師服務合同3篇
- 2025年度酒店客房部客房清潔工具采購合同3篇
- 2025年度綜合安防系統(tǒng)運維人員勞動合同范本3篇
- 關(guān)于2025年度消防設施維護保養(yǎng)合同匯編3篇
- 二零二五年度酒店客房預訂渠道拓展與傭金分配合同3篇
- 2025年度互聯(lián)網(wǎng)企業(yè)高級管理人員勞動合同模板2篇
- 二零二五年度企業(yè)員工合同模板匯編:試用期管理篇3篇
- 農(nóng)村建房施工安全責任主體確認與責任劃分合同(2025)3篇
- 2025年度養(yǎng)殖場養(yǎng)殖場用工服務合同3篇
- 2025年度農(nóng)村宅基地房屋買賣及文化遺產(chǎn)傳承保護合同
- 2024年加油站的年度工作總結(jié)范文(2篇)
- 甲醇制氫生產(chǎn)裝置計算書
- T-JSREA 32-2024 電化學儲能電站消防驗收規(guī)范
- 2025年上半年江蘇省常州市文廣旅局下屬事業(yè)單位招聘4人重點基礎提升(共500題)附帶答案詳解
- 2023-2024學年福建省泉州市石獅市三年級(上)期末數(shù)學試卷
- 新時代高校馬克思主義學院內(nèi)涵式發(fā)展的現(xiàn)狀和現(xiàn)實進路
- 【MOOC】隧道工程-中南大學 中國大學慕課MOOC答案
- 紅色經(jīng)典影片與近現(xiàn)代中國發(fā)展學習通超星期末考試答案章節(jié)答案2024年
- 劇作策劃與管理智慧樹知到期末考試答案2024年
- 鐵路基礎知識考試題庫500題(單選、多選、判斷)
- 2022年合理使用抗生素試題
評論
0/150
提交評論